Medical management of lung cancer: Experience in C hina
Y Shi, Y Sun - Thoracic Cancer, 2015 - Wiley Online Library
Lung cancer is the leading cause of death from cancer worldwide, as well as in C hina. A
multidisciplinary treatment strategy for lung cancer, which includes medical and radiation …
multidisciplinary treatment strategy for lung cancer, which includes medical and radiation …
[HTML][HTML] Defining the role of tyrosine kinase inhibitors in early stage non-small cell lung cancer
S Lampaki, G Lazaridis, K Zarogoulidis… - Journal of …, 2015 - ncbi.nlm.nih.gov
Historical, the non-small cell lung cancer (NSCLC) was as a united disease entity and the
chemotherapy to the metastatic cancer had limited results. Recent studies for the metastatic …
chemotherapy to the metastatic cancer had limited results. Recent studies for the metastatic …
[HTML][HTML] Meta-analysis of EGFR tyrosine kinase inhibitors compared with chemotherapy as second-line treatment in pretreated advanced non-small cell lung cancer
N Li, L Yang, W Ou, L Zhang, S Zhang, S Wang - PLoS One, 2014 - journals.plos.org
Background Since efficacy and safety of epidermal growth factor receptor tyrosine kinase
inhibitors (EGFR-TKIs) versus chemotherapy in the treatment of patients with pretreated …
inhibitors (EGFR-TKIs) versus chemotherapy in the treatment of patients with pretreated …
Epidermal growth factor receptor tyrosine kinase inhibitors in early-stage nonsmall cell lung cancer
JN Spaans, GD Goss - Current opinion in oncology, 2015 - journals.lww.com
There are no data to support the use of adjuvant EGFR-TKIs in unselected early-stage
NSCLC. Although EGFR-TKIs hold promise as adjuvant therapy in patients whose tumors …
NSCLC. Although EGFR-TKIs hold promise as adjuvant therapy in patients whose tumors …
[HTML][HTML] Adjuvant molecularly targeted therapy—epidermal growth factor tyrosine kinase inhibition and beyond
JW Neal, LV Sequist - Translational Lung Cancer Research, 2013 - ncbi.nlm.nih.gov
In stage IV non-small cell lung cancer (NSCLC), DNA molecular testing for mutations in
epidermal growth factor receptor (EGFR) and gene rearrangements of anaplastic lymphoma …
epidermal growth factor receptor (EGFR) and gene rearrangements of anaplastic lymphoma …
How to Personalize Perioperative Chemotherapy in Early Non-small Cell Lung Cancer?
S Carnio, P Bironzo, S Novello, GV Scagliotti - … Therapeutic Strategies in …, 2014 - Springer
Disseminated micrometastatic disease often limits the effectiveness of aggressive
locoregional treatment strategies in operable non-small cell lung cancer (NSCLC). The …
locoregional treatment strategies in operable non-small cell lung cancer (NSCLC). The …